AHIMA's new toolkit to increase focus on patient safety identifier

As part of its grassroots campaign to spur discussion about patient safety identifiers, AHIMA has released a new toolkit it hopes will be used to spread the word.

AHIMA’s MyHealthID campaign, which advocates for the creation of a voluntary patient safety identifier, relies in large part on getting 100,000 signatures in 30 days on a WhiteHouse.gov petition between March 20 and April 19.

AHIMA is taking its campaign straight to the White House because of the federal prohibition on the discussion of a unique patient identifier by legislators. This ban prevents government health officials from discussing one of the most viable ways of improving patient matching and reducing the risk of medical errors, according to AHIMA.

The toolkit is designed to help health information management professionals raise awareness for the White House petition and help them become ambassadors for the campaign’s message.

Resources provided in the toolkit include the following:

  • A template for an article that AHIMA members can send to local and national patient and consumer publications
  • A template for articles targeted to healthcare industry and trade publications
  • A template for e-mails that members can send to friends and family members educating them on the need for an identifier
  • Suggestions for creating Twitter and Facebook accounts so that members can advance the #MyHealthID message on social media, and samples of social media posts
  • Tips for working and interacting with the media
  • A template for press releases on MyHealthID
  • Graphics and images that can be circulated with the press and on social media

The toolkit also helps identify talking points and strategy for the campaign. AHIMA’s MyHealthID initiative proposes:

  • A voluntary patient safety identifier system in which individual patients could choose if they wish to participate.
  • A system where consumers select their own identifier, much as they do when they select usernames, passwords, or e-mail addresses.
  • A unique identifier for each individual that can be used when provided by the patient to access medical records.

A link to the White House petition will appear on the AHIMA website when the petition goes live March 20.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.